Super-sentinel chickens and detection of low-pathogenicity influenza virus

Emerging Infectious Diseases

Volumn 13, Issue 10, 2007, Pages 1608-1610

  Marcus, Philip I ^a   Girshick, Theodore ^b   Van Der Heide, Louis ^a   Sekellick, Margaret J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Charles River Specific Pathogen Free Avian Supplies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ARTICLE; CHICKEN; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PATHOGENICITY; SEROCONVERSION; VIRUS DETECTION;

EID: 35548952751     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1310.061552     Document Type: Article

References (15)

1. Cardona C. Low-pathogenicity avian influenza virus outbreaks in commercial poultry in California. In: The threat of pandemic influenza: are we ready? Washington: National Academies Press; 2005. p. 243-53.
2. Chin PS, Hoffman E, Webby R, Webster RG, Guan Y, Peiris M, et al. Molecular evolution of H6 influenza viruses from poultry in southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry. J Virol. 2002;76:507-16.
3. Lee C-W, Swayne DE, Linares JA, Senns DA, Suarez DI. H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20 years? J Virol. 2005;79:11412-21.
4. Kuiken T, Leighton FA, Fouchier RAM, LeDuc JW, Peitis JSM, Schdel A, et al. Pathogen surveillance in animals. Science. 2005;309:1680-1.
5. Sekellick MJ, Ferrandino AF, Hopkins DA, Marcus PI. Chicken interferon gene: cloning, expression, and analysis. J Interferon Res. 1994;14:71-9.
6. Marcus PI, van der Heide L, Sekellick MJ. Interferon action on avian viruses. I. Oral administration of chicken interferon-α ameliorates Newcastle disease. J Interferon Cytokine Res. 1999;19:881-5.
7. Pei J, Sekellick MJ, Marcus PI, Choi I-S, Collisson EW. Chicken interferon type I inhibits infectious bronchitis virus (IBV) replication and associated respiratory illness. J Interferon Cytokine Res. 2001;21:1071-7.
8. Mo CW, Cao TC, Lim BL. The in vivo and in vitro effects of chicken interferon-alpha on infectious bursal disease virus and Newcastle disease infection. Avian Dis. 2001;45:389-99.
9. Lu H, Castro AE. Evaluation of the infectivity, length of infection, and immune response of a low-pathogenicity H7N2 avian influenza virus in specific-pathogen-free chickens. Avian Dis. 2004;48:263-70.
10. Sekellick MJ, Carra SA, Bowman A, Marcus PI. Transient resistance of influenza virus to interferon action attributed to random packaging and activity of NS genes. J Interferon Cytokine Res. 2000;20:963-70.
11. Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL. Amelioration of influenza pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol. 2007;81:1838-47.
12. Beilharz MW, Fleischmann WR Jr, editors. Special topics issue: oral use of interferons and cytokines. J Interferon Cytokine Res. 1999;19:813-979.
13. Suresh M, Karaca K, Foster D, Sharma JM. Molecular and functional characterization of turkey interferon. J Virol. 1995;69:8159-63.
14. Xia C, Liu J, Wu ZG, Lin CY, Wang M. The interferon-alpha genes from three chicken lines and its effects on H9N2 influenza viruses. Anim Biotechnol. 2004;15:77-88.
15. Schultz U, Rinderle C, Sekellick MJ, Marcus PI, Staeheli P. Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur J Biochem. 1995;229:73-6.